Registry study for people with otoferlin hearing loss
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study builds a patient registry and tracks the natural history of hearing loss in people whose genetic test shows changes in the otoferlin (OTOF) gene. It may help researchers understand how hearing symptoms progress over time and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have genetic test results showing hearing-related changes in both copies of the OTOF gene (biallelic variants).
- Your genetic diagnosis must specifically be otoferlin (OTOF).
- You need an audiometry test (hearing test) to match the study criteria.
- You do not have genetic test evidence of a different (non-OTOF) cause of hearing loss.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks people with hearing loss caused by changes in the CABP2 gene. It aims to understand how the condition develops over time.
This study follows people with hearing loss caused by changes (mutations) in the otoferlin gene to better understand how hearing and hearing-related test results change over time. It may help researchers prepare for future treatments by building a clear picture of the natural course of the condition.
This trial tests a one-time gene therapy delivered into the ear to improve hearing in people with certain OTOF gene changes. It studies safety and how well the treatment can work, especially in children and infants, as doctors monitor hearing tests for up to 48 weeks.
This study follows up with people who received a gene therapy (AAVAnc80-hOTOF) in a previous clinical trial. It checks how well the treatment works over time and how safe it is.
This study follows children with hearing loss caused by changes in specific genes (GJB2 or OTOF). It helps researchers understand how hearing develops over time and how children may do with or without cochlear implants.
This study looks at the genes that cause a specific type of hearing loss called auditory neuropathy spectrum disorder (ANSD), where sound reaches the ear but the brain has trouble processing it. By studying DNA from people with this condition, researchers hope to better understand the genetic causes and improve diagnosis and treatment.
Hear when a new Hearing Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.